Skip to content

Mesa Laboratories MLAB Debt Instrument Face Amount

Debt Instrument Face Amount at other companies

STERIS logo
STERISSTE

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:LineOfCredit.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's debt instrument face amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's debt instrument face amount?
Mesa Laboratories (MLAB) reported debt instrument face amount of $84.5M in Q1 2026.
How has Mesa Laboratories's debt instrument face amount changed year-over-year?
Mesa Laboratories's debt instrument face amount increased by 745.0% year-over-year, from $10M to $84.5M.
What is the long-term trend for Mesa Laboratories's debt instrument face amount?
Over 2 years (2024 to 2026), Mesa Laboratories's debt instrument face amount has grown at a 29.4% compound annual growth rate (CAGR), from $50.5M to $84.5M.
What does debt instrument face amount mean?
This represents the total principal or par value of outstanding debt instruments, excluding any premiums, discounts, or accrued interest. It provides a clear view of the total contractual financial obligation owed to creditors at maturity. Investors use this metric to evaluate the company's total leverage position and the scale of its long-term capital structure.